Avery-Kiejda KA - Search Results

1

STaRRRT: a table of short tandem repeats in regulatory regions of the human genome.

Bolton KA, Ross JP, Grice DM, Bowden NA, Holliday EG, Avery-Kiejda KA, Scott RJ. Bolton KA, et al. BMC Genomics. 2013 Nov 15;14:795. doi: 10.1186/1471-2164-14-795. BMC Genomics. 2013. PMID: 24228761 Free PMC article.

2

Temozolomide induces senescence but not apoptosis in human melanoma cells.

Mhaidat NM, Zhang XD, Allen J, Avery-Kiejda KA, Scott RJ, Hersey P. Mhaidat NM, et al. Br J Cancer. 2007 Nov 5;97(9):1225-33. doi: 10.1038/sj.bjc.6604017. Epub 2007 Oct 30. Br J Cancer. 2007. PMID: 17968428 Free PMC article.

3

Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.

Avery-Kiejda KA, Zhang XD, Adams LJ, Scott RJ, Vojtesek B, Lane DP, Hersey P. Avery-Kiejda KA, et al. Clin Cancer Res. 2008 Mar 15;14(6):1659-68. doi: 10.1158/1078-0432.CCR-07-1422. Epub 2008 Feb 29. Clin Cancer Res. 2008. PMID: 18310316 Free article.

4

Nucleotide excision repair gene expression after Cisplatin treatment in melanoma.

Bowden NA, Ashton KA, Avery-Kiejda KA, Zhang XD, Hersey P, Scott RJ. Bowden NA, et al. Cancer Res. 2010 Oct 15;70(20):7918-26. doi: 10.1158/0008-5472.CAN-10-0161. Epub 2010 Aug 31. Cancer Res. 2010. PMID: 20807809

5

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.

Wong MW, Nordfors C, Mossman D, Pecenpetelovska G, Avery-Kiejda KA, Talseth-Palmer B, Bowden NA, Scott RJ. Wong MW, et al. Breast Cancer Res Treat. 2011 Jun;127(3):853-9. doi: 10.1007/s10549-011-1443-0. Epub 2011 Mar 16. Breast Cancer Res Treat. 2011. PMID: 21409391

6

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.

Avery-Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, Talseth-Palmer BA, Rizos H, Zhang XD, Scott RJ, Hersey P. Avery-Kiejda KA, et al. BMC Cancer. 2011 May 27;11:203. doi: 10.1186/1471-2407-11-203. BMC Cancer. 2011. PMID: 21615965 Free PMC article.

7

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.

Wong-Brown MW, Avery-Kiejda KA, Bowden NA, Scott RJ. Wong-Brown MW, et al. Int J Cancer. 2014 Jan 15;134(2):301-5. doi: 10.1002/ijc.28361. Epub 2013 Sep 23. Int J Cancer. 2014. PMID: 23824750

8

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.

Bowden NA, Ashton KA, Vilain RE, Avery-Kiejda KA, Davey RJ, Murray HC, Budden T, Braye SG, Zhang XD, Hersey P, Scott RJ. Bowden NA, et al. PLoS One. 2013 Aug 5;8(8):e70424. doi: 10.1371/journal.pone.0070424. Print 2013. PLoS One. 2013. PMID: 23940574 Free PMC article.

9

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.

Avery-Kiejda KA, Morten B, Wong-Brown MW, Mathe A, Scott RJ. Avery-Kiejda KA, et al. Carcinogenesis. 2014 Mar;35(3):586-96. doi: 10.1093/carcin/bgt411. Epub 2013 Dec 11. Carcinogenesis. 2014. PMID: 24336193

10

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.

Avery-Kiejda KA, Braye SG, Mathe A, Forbes JF, Scott RJ. Avery-Kiejda KA, et al. BMC Cancer. 2014 Jan 31;14:51. doi: 10.1186/1471-2407-14-51. BMC Cancer. 2014. PMID: 24479446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters